Information only, not medical advice. Talk to your doctor or pharmacist.

Condition

Viral infections

2 approvals (2 source records) from January 1, 2025 through . Data pulled .

October 2025

Health Canada

Viral infections

HEPCLUDEX

BULEVIRTIDE (BULEVIRTIDE ACETATE) 2 MG

Company: GILEAD SCIENCES CANADA INC

Original market date:

Data pulled:

Condition mapped from Health Canada ATC J05AX28 BULEVIRTIDE.

  • DIN: 02560178
  • Drug code: 106325
  • DPD status: Marketed
  • Therapeutic class: J05AX28 BULEVIRTIDE

March 2025

Health Canada

Viral infections

XOFLUZA

BALOXAVIR MARBOXIL 80 MG

Company: HOFFMANN-LA ROCHE LIMITED

Original market date:

Data pulled:

Condition mapped from Health Canada ATC J05AX25 BALOXAVIR MARBOXIL.

  • DIN: 02524163
  • Drug code: 101320
  • DPD status: Marketed
  • Therapeutic class: J05AX25 BALOXAVIR MARBOXIL